Synthesis and biological activities of reveromycin A and spirofungin A derivatives.
Takeshi Shimizu, Takeo Usui, Makoto Fujikura, Makoto Kawatani, Tomoharu Satoh, Kiyotaka Machida, Naoki Kanoh, Je-Tae Woo, Hiroyuki Osada, Mikiko Sodeoka
Index: Bioorg. Med. Chem. Lett. 18(13) , 3756-60, (2008)
Full Text: HTML
Abstract
Various derivatives of reveromycin A, an inhibitor of eukaryotic cell growth, and spirofungin A, focusing on the 5S hydroxyl group and C18 hemisuccinyl group, were synthesized and their inhibitory effects on both the isoleucyl-tRNA synthetase activity and the survival of osteoclasts, and activities on the morphological reversion of src(ts)-NRK cells were examined. It was found that 2,3-dihydroreveromycin A is the promising derivative of reveromycin A based on the activity and stability.
Related Compounds
Related Articles:
Development and application of bioprobes for Mammalian cell cycle analyses.
2003-05-01
[Curr. Med. Chem. 10(9) , 727-32, (2003)]
Osteoclast-targeting small molecules for the treatment of neoplastic bone metastases.
2009-11-01
[Cancer Sci. 100(11) , 1999-2005, (2009)]
2008-04-01
[J. Pharmacol. Sci. 106(4) , 547-54, (2008)]
Creation of novel reveromycin derivatives by alcohol-added fermentation.
2013-04-01
[J. Antibiot. 66(4) , 247-50, (2013)]
2013-09-01
[Am. J. Orthod. Dentofacial Orthop. 144(3) , 368-80, (2013)]